Skip to content

Pramocaine

CARDIOVASCULAR SYSTEM

Also known as: pramocain, pramocaine hydrochloride, pramoxin, pramoxine, pramoxine HCl, pramoxine hydrochloride

OfpFDA approvedATC C05AD07ATC D04AB07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pramocaine is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 1976. DrugCentral lists 3 molecular targets, including SIGMAR1, Pgrmc1 and SCN1A|SCN2A|SCN3A. Recorded indications include Allergic otitis externa, Arthropod bite wound, Burn injury and Dry skin.

  • Approval status: ofp (first approved 1976 by the FDA).
  • Molecular targets: SIGMAR1, Pgrmc1 and SCN1A|SCN2A|SCN3A (3 listed in DrugCentral).
  • Indications: Allergic otitis externa, Arthropod bite wound, Burn injury, Dry skin and Eruption of skin and others.
  • ATC code: C05AD07 (Local anesthetics).
  • Molecular formula: C17H27NO3; molecular weight 293.41 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (21)

  • Allergic otitis externa
  • Arthropod bite wound
  • Burn injury
  • Dry skin
  • Eruption of skin
  • Hemorrhoids
  • Inflammatory dermatosis
  • Itching of ear
  • Itching of skin
  • Minor Bacterial Skin Infections
  • Minor Skin Wound Pain
  • Otitis externa
  • Prevent Minor Bacterial Skin Infection
  • Proctitis
  • Pruritus ani
  • Rectal pain
  • Skin irritation
  • Tinea corporis
  • Tinea cruris
  • Tinea pedis
  • Wound

Contraindications (40)

  • Abscess of intestine
  • Acute tuberculosis
  • Adrenal cortical hypofunction
  • Anastomosis of intestine
  • Anxiety
  • Atrophoderma
  • Benign prostatic hyperplasia
  • Chronic heart failure
  • Conduction disorder of the heart
  • Contact dermatitis
  • Denuded skin
  • Diabetes mellitus
  • Disorder of coronary artery
  • Diverticulitis of gastrointestinal tract
  • Fissure in skin
  • Fungal ear infection
  • Gastrointestinal fistula
  • Herpes simplex
  • Herpes zoster auricularis
  • Hypertensive disorder
  • Hyperthyroidism
  • Hypothyroidism
  • Infectious disease
  • Kidney disease
  • Measles
  • Mycosis
  • Nervousness
  • Open wound
  • Open-angle glaucoma
  • Ophthalmic herpes simplex
  • + 10 more

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
Sigma non-opioid intracellular receptor 1SIGMAR1unknownKi 7.29
Membrane-associated progesterone receptor component 1Pgrmc1unknownKi 6.20
Sodium channel alpha subunits; brain (Types I, II, III)SCN1A|SCN2A|SCN3AunknownIC50 4.67

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1976-08-13FDA—SEBELA IRELAND LTD

ATC classification

ATC codeTherapeutic hierarchy
C05AD07CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE › Local anesthetics
D04AB07DERMATOLOGICALS › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. › Anesthetics for topical use

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Macular degeneration1228.1
Chronic sinusitis522.8
Female genital tract fistula454.7
Paraesthesia oral420.5
Vaginal flatulence404.1
Procedural pain395.5
Proctitis364.4
Radiculopathy358.4
Vaginal discharge356.5
Oral candidiasis253.3
Frequent bowel movements213.6
Colitis ulcerative199.2

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Pramocaine is on its molecule page.

Molecular formulaC17H27NO3
Molecular weight293.41 g/mol
CAS number140-65-8
InChIKeyDQKXQSGTHWVTAD-UHFFFAOYSA-N
PubChem CID4886
CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Pramocaine used for?

DrugCentral lists the following indications for Pramocaine: Allergic otitis externa, Arthropod bite wound, Burn injury, Dry skin, Eruption of skin, Hemorrhoids, Inflammatory dermatosis and Itching of ear and others.

How does Pramocaine work?

Its molecular targets in DrugCentral include SIGMAR1, Pgrmc1 and SCN1A|SCN2A|SCN3A.

When was Pramocaine first approved?

Pramocaine was first approved by the FDA in 1976.

What is the chemical formula of Pramocaine?

Pramocaine has the molecular formula C17H27NO3 and a molecular weight of 293.41 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1976-08-13
AgencyFDA
Targets3
Indications21
FormulaC17H27NO3
DrugCentral ID3487
Interactive profile